Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DARE-C: Response-Guided Telaprevir Therapy for Early Chronic HCV
NCT01743521Phase 4Completed
- Sponsor
- The Kirby Institute
- Start
- Jan 2013
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telaprevir in chronic hepatitis C (CHC), sponsored by The Kirby Institute. Started Jan 2013; status: completed.
02
Drugs
telaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT01743521.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01743521.